Genentech goes offshore
Genentech is investing $140mm in a new biologic manufacturing plant in Singapore. The first commercial-scale microbial fermentation plant in Singapore, and a significant International investment by US-based Genentech. This is the latest of a number of international manufacturing and R&D centers being located in Singapore, and is a sign of the growing trend of biotechnology operations being globally distributed in specialized centers with favorable economics, worker, or other resource availability.
In a related post, David Rosen reports that Indian trade possibilities boggle the mind while on an Illinois trade mission to India.